Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history

被引:12
作者
McDowell, Michelle E. [1 ]
Occhipinti, Stefano [1 ]
Gardiner, Robert A. [2 ,3 ]
Chambers, Suzanne K. [2 ]
机构
[1] Griffith Univ, Sch Appl Psychol, Griffith Hlth Inst, Mt Gravatt, Qld 4111, Australia
[2] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4072, Australia
[3] Royal Brisbane Hosp, Dept Urol, Brisbane, Qld, Australia
关键词
prostate cancer; family history; early detection; CANCER; RELATIVES; RISK; METAANALYSIS;
D O I
10.1111/j.1464-410X.2012.11050.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To describe how a family history of prostate cancer influences men's prostate cancer testing behaviours, information support preferences, and motives for testing. SUBJECTS AND METHODS Men with a fi rst-degree family history (239 men) and a comparison sample from the general population of Queensland, Australia (289) aged 40-65 years, and no prior history of cancer. Cross-sectional, retrospective survey assessing: prevalence of prostate-specifi c antigen (PSA) testing and digital rectal examination (DRE); discussion of prostate cancer risks and benefi ts with a physician; prostate cancer information needs and preferences; motivations for testing. RESULTS Men with a family history were more likely to report: having ever had a PSA test (odds ratio [OR] 4.98; 95% confi dence interval [CI] 3.16-7.85), more PSA tests in their lifetimes (b 1.04; SE 0.40; 95% CI 0.26-1.82); to have had a DRE (OR 2.23; 95% CI 1.54-3.23); to have spoken to a doctor about prostate cancer (OR 3.72; 95% CI 2.30-6.02); and to have instigated these discussions (OR 1.74; 95% CI 1.13-2.70). Most men from both groups did not recall any discussion of the ` cons ' of prostate cancer testing with a doctor. Men with a family history reported a greater desire for information about prostate cancer prevention than did men without a family history. CONCLUSIONS Men with a family history are more concerned about getting prostate cancer and are tested more often; however, information needs, discussions about prostate cancer, and motivations for testing are similar to those of all men. There appears to be a disparity between public health approaches that promote informed decision-making and what is happening in practice.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 50 条
[11]   A "PSA Pyramid'' for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening [J].
Randazzo, Marco ;
Beatrice, Josef ;
Huber, Andreas ;
Grobholz, Rainer ;
Manka, Lukas ;
Chun, Felix K. ;
Recker, Franz ;
Kwiatkowski, Maciej .
EUROPEAN UROLOGY, 2015, 68 (04) :591-597
[12]   The Dilemma of Prostate-Specific Antigen Testing [J].
Leach, Robin ;
Thompson, Ian M. .
ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (11) :835-836
[13]   PSA Quo Vadis? It Is Reasonable to Start with Prostate-Specific Antigen Testing at the Age of 40! [J].
Boergermann, Christof ;
vom Dorp, Frank ;
Swoboda, Andreas ;
Ketteniss, Oskar ;
Becker, Markus ;
Ruebben, Herbert .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (06) :1190-1195
[14]   Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less [J].
Liu, Xin ;
Tang, Jie ;
Fei, Xiang ;
Li, Qiu-Yang .
IRANIAN JOURNAL OF PUBLIC HEALTH, 2015, 44 (11) :1466-1472
[15]   The use of prostate-specific antigen testing in men presenting with haematuria [J].
Bromage, Stephen J. ;
Napier-Hemy, Richard D. ;
Payne, Stephen R. ;
Pearce, Ian ;
McIntyre, Iain G. .
BJU INTERNATIONAL, 2006, 98 (06) :1221-1224
[16]   Prostate-specific antigen (PSA): A tumor marker in the diagnosis of prostate cancer [J].
Ohlendorf D. ;
Wanke E.M. ;
Braun M. ;
Oremek G.M. ;
Groneberg D.A. .
Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, 2017, 67 (4) :221-223
[17]   Capillary Blood for Prostate-specific Antigen Testing: The PSA-CAP Study [J].
Wallisch, Martin ;
Albers, Peter ;
Becker, Nikolaus ;
Boege, Friedrich ;
Hermsen, Derik ;
Londhe, Tanmay Ramesh ;
Lakes, Jale ;
Radtke, Jan Philipp ;
Krilaviciute, Agne ;
Seibold, Petra ;
Benner, Axel ;
Saadati, Maral ;
Holdenrieder, Stefan ;
Al-Monajjed, Rouvier .
EUROPEAN UROLOGY OPEN SCIENCE, 2025, 78 :28-31
[18]   Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer [J].
Iyer, Hari S. ;
Stone, Benjamin V. ;
Roscoe, Charlotte ;
Hsieh, Mei-Chin ;
Stroup, Antoinette M. ;
Wiggins, Charles L. ;
Schumacher, Fredrick R. ;
Gomez, Scarlett L. ;
Rebbeck, Timothy R. ;
Trinh, Quoc-Dien .
JAMA NETWORK OPEN, 2024, 7 (06)
[19]   Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research [J].
Littlejohns, Thomas J. ;
Travis, Ruth C. ;
Key, Tim J. ;
Allen, Naomi E. .
CANCER EPIDEMIOLOGY, 2016, 45 :40-46
[20]   Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy [J].
Oh, Jong J. ;
Jeong, Seong J. ;
Lee, Byung K. ;
Jeong, Chang W. ;
Byun, Seok-Soo ;
Hong, Sung K. ;
Lee, Sang E. .
BJU INTERNATIONAL, 2013, 112 (04) :E265-E271